Orbimed Advisors - ALPINE IMMUNE SCIENCES INC ownership

ALPINE IMMUNE SCIENCES INC's ticker is ALPN and the CUSIP is 02083G100. A total of 64 filers reported holding ALPINE IMMUNE SCIENCES INC in Q4 2022. The put-call ratio across all filers is 0.09 and the average weighting 0.6%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of ALPINE IMMUNE SCIENCES INC
ValueSharesWeighting
Q3 2023$46,734,228
+11.4%
4,081,5920.0%0.99%
+30.7%
Q2 2023$41,958,766
+33.2%
4,081,5920.0%0.76%
+22.8%
Q1 2023$31,509,890
+5.0%
4,081,5920.0%0.62%
+7.8%
Q4 2022$29,999,701
+2.1%
4,081,5920.0%0.57%
+5.1%
Q3 2022$29,387,000
-15.4%
4,081,5920.0%0.55%
-13.2%
Q2 2022$34,734,000
-5.1%
4,081,5920.0%0.63%
+5.9%
Q1 2022$36,612,000
-35.2%
4,081,5920.0%0.59%
-18.3%
Q4 2021$56,530,000
+29.8%
4,081,5920.0%0.73%
+51.8%
Q3 2021$43,551,000
+57.6%
4,081,592
+32.9%
0.48%
+71.1%
Q2 2021$27,639,000
-15.1%
3,070,9550.0%0.28%
-7.9%
Q1 2021$32,552,000
-15.9%
3,070,9550.0%0.30%
-10.3%
Q4 2020$38,694,000
+19.9%
3,070,955
-16.3%
0.34%
-16.5%
Q3 2020$32,268,000
-9.5%
3,670,9550.0%0.41%
-19.1%
Q2 2020$35,645,000
+237.2%
3,670,9550.0%0.50%
+182.0%
Q1 2020$10,572,000
-25.0%
3,670,9550.0%0.18%
-11.4%
Q4 2019$14,096,000
-3.0%
3,670,9550.0%0.20%
-27.2%
Q3 2019$14,537,000
-5.9%
3,670,9550.0%0.28%
+15.5%
Q2 2019$15,455,000
-38.6%
3,670,9550.0%0.24%
-38.7%
Q1 2019$25,183,000
+107.5%
3,670,955
+11.3%
0.39%
+74.1%
Q4 2018$12,139,000
-41.9%
3,298,5160.0%0.22%
-10.8%
Q3 2018$20,880,000
-16.4%
3,298,5160.0%0.25%
-15.8%
Q2 2018$24,970,000
-5.4%
3,298,5160.0%0.30%
-8.9%
Q1 2018$26,388,000
-28.6%
3,298,5160.0%0.33%
-30.0%
Q4 2017$36,943,000
-3.4%
3,298,5160.0%0.47%
+27.6%
Q3 2017$38,263,0003,298,5160.37%
Other shareholders
ALPINE IMMUNE SCIENCES INC shareholders Q4 2022
NameSharesValueWeighting ↓
Decheng Capital Management III (Cayman), LLC 6,708,288$76,809,89825.63%
Lynx1 Capital Management LP 2,404,614$27,532,83018.21%
GREAT POINT PARTNERS LLC 3,078,633$35,250,3486.42%
Ghost Tree Capital, LLC 664,132$7,604,3112.50%
Frazier Life Sciences Management, L.P. 2,985,757$34,186,9182.27%
Paradigm Biocapital Advisors LP 2,421,743$27,728,9571.88%
COMMODORE CAPITAL LP 1,325,000$15,171,2501.77%
Nan Fung Group Holdings Ltd 182,280$2,087,1061.69%
Omega Fund Management, LLC 153,700$1,759,8651.62%
Octagon Capital Advisors LP 750,000$8,587,5001.32%
View complete list of ALPINE IMMUNE SCIENCES INC shareholders